Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126424172 | 12642417 | 2 | F | 20160804 | 20160812 | 20160810 | 20160822 | EXP | BR-ALEXION-A201605690 | ALEXION | 13.16 | YR | M | Y | 53.00000 | KG | 20160822 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126424172 | 12642417 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 600 MG, QW | 125166 | 600 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | /wk | ||||||
| 126424172 | 12642417 | 2 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, Q2W | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | ||||||
| 126424172 | 12642417 | 3 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | UNK | 125166 | CONCENTRATE FOR SOLUTION FOR INFUSION | |||||||||
| 126424172 | 12642417 | 4 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, Q3W | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | Q3W | ||||||
| 126424172 | 12642417 | 5 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, Q2W | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | ||||||
| 126424172 | 12642417 | 6 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 1200 MG, Q2W | 125166 | 1200 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | ||||||
| 126424172 | 12642417 | 7 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 600 MG, UNK | 125166 | 600 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | |||||||
| 126424172 | 12642417 | 8 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 1200 MG, UNK | 125166 | 1200 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | |||||||
| 126424172 | 12642417 | 9 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 0 | |||||||||||
| 126424172 | 12642417 | 10 | C | ENALAPRIL | ENALAPRIL | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126424172 | 12642417 | 1 | Haemolytic uraemic syndrome |
| 126424172 | 12642417 | 9 | Hypertension |
| 126424172 | 12642417 | 10 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126424172 | 12642417 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126424172 | 12642417 | Haemolysis | |
| 126424172 | 12642417 | Inappropriate schedule of drug administration | |
| 126424172 | 12642417 | Incorrect dose administered | |
| 126424172 | 12642417 | Thrombocytopenia | |
| 126424172 | 12642417 | Thrombotic microangiopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126424172 | 12642417 | 1 | 20140221 | 20140228 | 0 | |
| 126424172 | 12642417 | 2 | 20140307 | 0 | ||
| 126424172 | 12642417 | 3 | 201512 | 0 | ||
| 126424172 | 12642417 | 4 | 2016 | 0 | ||
| 126424172 | 12642417 | 5 | 2016 | 0 | ||
| 126424172 | 12642417 | 6 | 2016 | 0 | ||
| 126424172 | 12642417 | 7 | 20160804 | 20160810 | 0 | |
| 126424172 | 12642417 | 8 | 20160810 | 0 |